Request for Covid-19 Impact Assessment of this Report
The United States Bioactive Protein and Peptides market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Bioactive Protein and Peptides market, reaching US$ million by the year 2028. As for the Europe Bioactive Protein and Peptides landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Bioactive Protein and Peptides players cover Archer Daniels Midland Company (ADM), Kerry Group, Cargill Inc., and Omega Protein Corporation, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Bioactive Protein and Peptides market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Dairy
Egg & Meat
Gelatin
Fish & Insects
Seafood
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Medicine
Cosmetic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Archer Daniels Midland Company (ADM)
Kerry Group
Cargill Inc.
Omega Protein Corporation
Bunge Ltd
EI du Pont de Nemours
Fonterra Co-operative Group Ltd
Royal DSM
CHS
Gelita
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Bioactive Protein and Peptides Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Bioactive Protein and Peptides by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Bioactive Protein and Peptides by Country/Region, 2017, 2022 & 2028
2.2 Bioactive Protein and Peptides Segment by Type
2.2.1 Dairy
2.2.2 Egg & Meat
2.2.3 Gelatin
2.2.4 Fish & Insects
2.2.5 Seafood
2.2.6 Other
2.3 Bioactive Protein and Peptides Sales by Type
2.3.1 Global Bioactive Protein and Peptides Sales Market Share by Type (2017-2022)
2.3.2 Global Bioactive Protein and Peptides Revenue and Market Share by Type (2017-2022)
2.3.3 Global Bioactive Protein and Peptides Sale Price by Type (2017-2022)
2.4 Bioactive Protein and Peptides Segment by Application
2.4.1 Medicine
2.4.2 Cosmetic
2.4.3 Other
2.5 Bioactive Protein and Peptides Sales by Application
2.5.1 Global Bioactive Protein and Peptides Sale Market Share by Application (2017-2022)
2.5.2 Global Bioactive Protein and Peptides Revenue and Market Share by Application (2017-2022)
2.5.3 Global Bioactive Protein and Peptides Sale Price by Application (2017-2022)
3 Global Bioactive Protein and Peptides by Company
3.1 Global Bioactive Protein and Peptides Breakdown Data by Company
3.1.1 Global Bioactive Protein and Peptides Annual Sales by Company (2020-2022)
3.1.2 Global Bioactive Protein and Peptides Sales Market Share by Company (2020-2022)
3.2 Global Bioactive Protein and Peptides Annual Revenue by Company (2020-2022)
3.2.1 Global Bioactive Protein and Peptides Revenue by Company (2020-2022)
3.2.2 Global Bioactive Protein and Peptides Revenue Market Share by Company (2020-2022)
3.3 Global Bioactive Protein and Peptides Sale Price by Company
3.4 Key Manufacturers Bioactive Protein and Peptides Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Bioactive Protein and Peptides Product Location Distribution
3.4.2 Players Bioactive Protein and Peptides Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Bioactive Protein and Peptides by Geographic Region
4.1 World Historic Bioactive Protein and Peptides Market Size by Geographic Region (2017-2022)
4.1.1 Global Bioactive Protein and Peptides Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Bioactive Protein and Peptides Annual Revenue by Geographic Region
4.2 World Historic Bioactive Protein and Peptides Market Size by Country/Region (2017-2022)
4.2.1 Global Bioactive Protein and Peptides Annual Sales by Country/Region (2017-2022)
4.2.2 Global Bioactive Protein and Peptides Annual Revenue by Country/Region
4.3 Americas Bioactive Protein and Peptides Sales Growth
4.4 APAC Bioactive Protein and Peptides Sales Growth
4.5 Europe Bioactive Protein and Peptides Sales Growth
4.6 Middle East & Africa Bioactive Protein and Peptides Sales Growth
5 Americas
5.1 Americas Bioactive Protein and Peptides Sales by Country
5.1.1 Americas Bioactive Protein and Peptides Sales by Country (2017-2022)
5.1.2 Americas Bioactive Protein and Peptides Revenue by Country (2017-2022)
5.2 Americas Bioactive Protein and Peptides Sales by Type
5.3 Americas Bioactive Protein and Peptides Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Bioactive Protein and Peptides Sales by Region
6.1.1 APAC Bioactive Protein and Peptides Sales by Region (2017-2022)
6.1.2 APAC Bioactive Protein and Peptides Revenue by Region (2017-2022)
6.2 APAC Bioactive Protein and Peptides Sales by Type
6.3 APAC Bioactive Protein and Peptides Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Bioactive Protein and Peptides by Country
7.1.1 Europe Bioactive Protein and Peptides Sales by Country (2017-2022)
7.1.2 Europe Bioactive Protein and Peptides Revenue by Country (2017-2022)
7.2 Europe Bioactive Protein and Peptides Sales by Type
7.3 Europe Bioactive Protein and Peptides Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Bioactive Protein and Peptides by Country
8.1.1 Middle East & Africa Bioactive Protein and Peptides Sales by Country (2017-2022)
8.1.2 Middle East & Africa Bioactive Protein and Peptides Revenue by Country (2017-2022)
8.2 Middle East & Africa Bioactive Protein and Peptides Sales by Type
8.3 Middle East & Africa Bioactive Protein and Peptides Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Bioactive Protein and Peptides
10.3 Manufacturing Process Analysis of Bioactive Protein and Peptides
10.4 Industry Chain Structure of Bioactive Protein and Peptides
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Bioactive Protein and Peptides Distributors
11.3 Bioactive Protein and Peptides Customer
12 World Forecast Review for Bioactive Protein and Peptides by Geographic Region
12.1 Global Bioactive Protein and Peptides Market Size Forecast by Region
12.1.1 Global Bioactive Protein and Peptides Forecast by Region (2023-2028)
12.1.2 Global Bioactive Protein and Peptides Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Bioactive Protein and Peptides Forecast by Type
12.7 Global Bioactive Protein and Peptides Forecast by Application
13 Key Players Analysis
13.1 Archer Daniels Midland Company (ADM)
13.1.1 Archer Daniels Midland Company (ADM) Company Information
13.1.2 Archer Daniels Midland Company (ADM) Bioactive Protein and Peptides Product Offered
13.1.3 Archer Daniels Midland Company (ADM) Bioactive Protein and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Archer Daniels Midland Company (ADM) Main Business Overview
13.1.5 Archer Daniels Midland Company (ADM) Latest Developments
13.2 Kerry Group
13.2.1 Kerry Group Company Information
13.2.2 Kerry Group Bioactive Protein and Peptides Product Offered
13.2.3 Kerry Group Bioactive Protein and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Kerry Group Main Business Overview
13.2.5 Kerry Group Latest Developments
13.3 Cargill Inc.
13.3.1 Cargill Inc. Company Information
13.3.2 Cargill Inc. Bioactive Protein and Peptides Product Offered
13.3.3 Cargill Inc. Bioactive Protein and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Cargill Inc. Main Business Overview
13.3.5 Cargill Inc. Latest Developments
13.4 Omega Protein Corporation
13.4.1 Omega Protein Corporation Company Information
13.4.2 Omega Protein Corporation Bioactive Protein and Peptides Product Offered
13.4.3 Omega Protein Corporation Bioactive Protein and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Omega Protein Corporation Main Business Overview
13.4.5 Omega Protein Corporation Latest Developments
13.5 Bunge Ltd
13.5.1 Bunge Ltd Company Information
13.5.2 Bunge Ltd Bioactive Protein and Peptides Product Offered
13.5.3 Bunge Ltd Bioactive Protein and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bunge Ltd Main Business Overview
13.5.5 Bunge Ltd Latest Developments
13.6 EI du Pont de Nemours
13.6.1 EI du Pont de Nemours Company Information
13.6.2 EI du Pont de Nemours Bioactive Protein and Peptides Product Offered
13.6.3 EI du Pont de Nemours Bioactive Protein and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 EI du Pont de Nemours Main Business Overview
13.6.5 EI du Pont de Nemours Latest Developments
13.7 Fonterra Co-operative Group Ltd
13.7.1 Fonterra Co-operative Group Ltd Company Information
13.7.2 Fonterra Co-operative Group Ltd Bioactive Protein and Peptides Product Offered
13.7.3 Fonterra Co-operative Group Ltd Bioactive Protein and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Fonterra Co-operative Group Ltd Main Business Overview
13.7.5 Fonterra Co-operative Group Ltd Latest Developments
13.8 Royal DSM
13.8.1 Royal DSM Company Information
13.8.2 Royal DSM Bioactive Protein and Peptides Product Offered
13.8.3 Royal DSM Bioactive Protein and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Royal DSM Main Business Overview
13.8.5 Royal DSM Latest Developments
13.9 CHS
13.9.1 CHS Company Information
13.9.2 CHS Bioactive Protein and Peptides Product Offered
13.9.3 CHS Bioactive Protein and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 CHS Main Business Overview
13.9.5 CHS Latest Developments
13.10 Gelita
13.10.1 Gelita Company Information
13.10.2 Gelita Bioactive Protein and Peptides Product Offered
13.10.3 Gelita Bioactive Protein and Peptides Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Gelita Main Business Overview
13.10.5 Gelita Latest Developments
14 Research Findings and Conclusion
Table 1. Bioactive Protein and Peptides Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Bioactive Protein and Peptides Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Dairy
Table 4. Major Players of Egg & Meat
Table 5. Major Players of Gelatin
Table 6. Major Players of Fish & Insects
Table 7. Major Players of Seafood
Table 8. Major Players of Other
Table 9. Global Bioactive Protein and Peptides Sales by Type (2017-2022) & (KG)
Table 10. Global Bioactive Protein and Peptides Sales Market Share by Type (2017-2022)
Table 11. Global Bioactive Protein and Peptides Revenue by Type (2017-2022) & ($ million)
Table 12. Global Bioactive Protein and Peptides Revenue Market Share by Type (2017-2022)
Table 13. Global Bioactive Protein and Peptides Sale Price by Type (2017-2022) & (US$/G)
Table 14. Global Bioactive Protein and Peptides Sales by Application (2017-2022) & (KG)
Table 15. Global Bioactive Protein and Peptides Sales Market Share by Application (2017-2022)
Table 16. Global Bioactive Protein and Peptides Revenue by Application (2017-2022)
Table 17. Global Bioactive Protein and Peptides Revenue Market Share by Application (2017-2022)
Table 18. Global Bioactive Protein and Peptides Sale Price by Application (2017-2022) & (US$/G)
Table 19. Global Bioactive Protein and Peptides Sales by Company (2020-2022) & (KG)
Table 20. Global Bioactive Protein and Peptides Sales Market Share by Company (2020-2022)
Table 21. Global Bioactive Protein and Peptides Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Bioactive Protein and Peptides Revenue Market Share by Company (2020-2022)
Table 23. Global Bioactive Protein and Peptides Sale Price by Company (2020-2022) & (US$/G)
Table 24. Key Manufacturers Bioactive Protein and Peptides Producing Area Distribution and Sales Area
Table 25. Players Bioactive Protein and Peptides Products Offered
Table 26. Bioactive Protein and Peptides Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Bioactive Protein and Peptides Sales by Geographic Region (2017-2022) & (KG)
Table 30. Global Bioactive Protein and Peptides Sales Market Share Geographic Region (2017-2022)
Table 31. Global Bioactive Protein and Peptides Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Bioactive Protein and Peptides Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Bioactive Protein and Peptides Sales by Country/Region (2017-2022) & (KG)
Table 34. Global Bioactive Protein and Peptides Sales Market Share by Country/Region (2017-2022)
Table 35. Global Bioactive Protein and Peptides Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Bioactive Protein and Peptides Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Bioactive Protein and Peptides Sales by Country (2017-2022) & (KG)
Table 38. Americas Bioactive Protein and Peptides Sales Market Share by Country (2017-2022)
Table 39. Americas Bioactive Protein and Peptides Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Bioactive Protein and Peptides Revenue Market Share by Country (2017-2022)
Table 41. Americas Bioactive Protein and Peptides Sales by Type (2017-2022) & (KG)
Table 42. Americas Bioactive Protein and Peptides Sales Market Share by Type (2017-2022)
Table 43. Americas Bioactive Protein and Peptides Sales by Application (2017-2022) & (KG)
Table 44. Americas Bioactive Protein and Peptides Sales Market Share by Application (2017-2022)
Table 45. APAC Bioactive Protein and Peptides Sales by Region (2017-2022) & (KG)
Table 46. APAC Bioactive Protein and Peptides Sales Market Share by Region (2017-2022)
Table 47. APAC Bioactive Protein and Peptides Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Bioactive Protein and Peptides Revenue Market Share by Region (2017-2022)
Table 49. APAC Bioactive Protein and Peptides Sales by Type (2017-2022) & (KG)
Table 50. APAC Bioactive Protein and Peptides Sales Market Share by Type (2017-2022)
Table 51. APAC Bioactive Protein and Peptides Sales by Application (2017-2022) & (KG)
Table 52. APAC Bioactive Protein and Peptides Sales Market Share by Application (2017-2022)
Table 53. Europe Bioactive Protein and Peptides Sales by Country (2017-2022) & (KG)
Table 54. Europe Bioactive Protein and Peptides Sales Market Share by Country (2017-2022)
Table 55. Europe Bioactive Protein and Peptides Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Bioactive Protein and Peptides Revenue Market Share by Country (2017-2022)
Table 57. Europe Bioactive Protein and Peptides Sales by Type (2017-2022) & (KG)
Table 58. Europe Bioactive Protein and Peptides Sales Market Share by Type (2017-2022)
Table 59. Europe Bioactive Protein and Peptides Sales by Application (2017-2022) & (KG)
Table 60. Europe Bioactive Protein and Peptides Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Bioactive Protein and Peptides Sales by Country (2017-2022) & (KG)
Table 62. Middle East & Africa Bioactive Protein and Peptides Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Bioactive Protein and Peptides Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Bioactive Protein and Peptides Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Bioactive Protein and Peptides Sales by Type (2017-2022) & (KG)
Table 66. Middle East & Africa Bioactive Protein and Peptides Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Bioactive Protein and Peptides Sales by Application (2017-2022) & (KG)
Table 68. Middle East & Africa Bioactive Protein and Peptides Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Bioactive Protein and Peptides
Table 70. Key Market Challenges & Risks of Bioactive Protein and Peptides
Table 71. Key Industry Trends of Bioactive Protein and Peptides
Table 72. Bioactive Protein and Peptides Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Bioactive Protein and Peptides Distributors List
Table 75. Bioactive Protein and Peptides Customer List
Table 76. Global Bioactive Protein and Peptides Sales Forecast by Region (2023-2028) & (KG)
Table 77. Global Bioactive Protein and Peptides Sales Market Forecast by Region
Table 78. Global Bioactive Protein and Peptides Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Bioactive Protein and Peptides Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Bioactive Protein and Peptides Sales Forecast by Country (2023-2028) & (KG)
Table 81. Americas Bioactive Protein and Peptides Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Bioactive Protein and Peptides Sales Forecast by Region (2023-2028) & (KG)
Table 83. APAC Bioactive Protein and Peptides Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Bioactive Protein and Peptides Sales Forecast by Country (2023-2028) & (KG)
Table 85. Europe Bioactive Protein and Peptides Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Bioactive Protein and Peptides Sales Forecast by Country (2023-2028) & (KG)
Table 87. Middle East & Africa Bioactive Protein and Peptides Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Bioactive Protein and Peptides Sales Forecast by Type (2023-2028) & (KG)
Table 89. Global Bioactive Protein and Peptides Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Bioactive Protein and Peptides Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Bioactive Protein and Peptides Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Bioactive Protein and Peptides Sales Forecast by Application (2023-2028) & (KG)
Table 93. Global Bioactive Protein and Peptides Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Bioactive Protein and Peptides Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Bioactive Protein and Peptides Revenue Market Share Forecast by Application (2023-2028)
Table 96. Archer Daniels Midland Company (ADM) Basic Information, Bioactive Protein and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 97. Archer Daniels Midland Company (ADM) Bioactive Protein and Peptides Product Offered
Table 98. Archer Daniels Midland Company (ADM) Bioactive Protein and Peptides Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 99. Archer Daniels Midland Company (ADM) Main Business
Table 100. Archer Daniels Midland Company (ADM) Latest Developments
Table 101. Kerry Group Basic Information, Bioactive Protein and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 102. Kerry Group Bioactive Protein and Peptides Product Offered
Table 103. Kerry Group Bioactive Protein and Peptides Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 104. Kerry Group Main Business
Table 105. Kerry Group Latest Developments
Table 106. Cargill Inc. Basic Information, Bioactive Protein and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 107. Cargill Inc. Bioactive Protein and Peptides Product Offered
Table 108. Cargill Inc. Bioactive Protein and Peptides Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 109. Cargill Inc. Main Business
Table 110. Cargill Inc. Latest Developments
Table 111. Omega Protein Corporation Basic Information, Bioactive Protein and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 112. Omega Protein Corporation Bioactive Protein and Peptides Product Offered
Table 113. Omega Protein Corporation Bioactive Protein and Peptides Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 114. Omega Protein Corporation Main Business
Table 115. Omega Protein Corporation Latest Developments
Table 116. Bunge Ltd Basic Information, Bioactive Protein and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 117. Bunge Ltd Bioactive Protein and Peptides Product Offered
Table 118. Bunge Ltd Bioactive Protein and Peptides Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 119. Bunge Ltd Main Business
Table 120. Bunge Ltd Latest Developments
Table 121. EI du Pont de Nemours Basic Information, Bioactive Protein and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 122. EI du Pont de Nemours Bioactive Protein and Peptides Product Offered
Table 123. EI du Pont de Nemours Bioactive Protein and Peptides Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 124. EI du Pont de Nemours Main Business
Table 125. EI du Pont de Nemours Latest Developments
Table 126. Fonterra Co-operative Group Ltd Basic Information, Bioactive Protein and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 127. Fonterra Co-operative Group Ltd Bioactive Protein and Peptides Product Offered
Table 128. Fonterra Co-operative Group Ltd Bioactive Protein and Peptides Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 129. Fonterra Co-operative Group Ltd Main Business
Table 130. Fonterra Co-operative Group Ltd Latest Developments
Table 131. Royal DSM Basic Information, Bioactive Protein and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 132. Royal DSM Bioactive Protein and Peptides Product Offered
Table 133. Royal DSM Bioactive Protein and Peptides Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 134. Royal DSM Main Business
Table 135. Royal DSM Latest Developments
Table 136. CHS Basic Information, Bioactive Protein and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 137. CHS Bioactive Protein and Peptides Product Offered
Table 138. CHS Bioactive Protein and Peptides Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 139. CHS Main Business
Table 140. CHS Latest Developments
Table 141. Gelita Basic Information, Bioactive Protein and Peptides Manufacturing Base, Sales Area and Its Competitors
Table 142. Gelita Bioactive Protein and Peptides Product Offered
Table 143. Gelita Bioactive Protein and Peptides Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 144. Gelita Main Business
Table 145. Gelita Latest Developments
List of Figures
Figure 1. Picture of Bioactive Protein and Peptides
Figure 2. Bioactive Protein and Peptides Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Bioactive Protein and Peptides Sales Growth Rate 2017-2028 (KG)
Figure 7. Global Bioactive Protein and Peptides Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Bioactive Protein and Peptides Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Dairy
Figure 10. Product Picture of Egg & Meat
Figure 11. Product Picture of Gelatin
Figure 12. Product Picture of Fish & Insects
Figure 13. Product Picture of Seafood
Figure 14. Product Picture of Other
Figure 15. Global Bioactive Protein and Peptides Sales Market Share by Type in 2021
Figure 16. Global Bioactive Protein and Peptides Revenue Market Share by Type (2017-2022)
Figure 17. Bioactive Protein and Peptides Consumed in Medicine
Figure 18. Global Bioactive Protein and Peptides Market: Medicine (2017-2022) & (KG)
Figure 19. Bioactive Protein and Peptides Consumed in Cosmetic
Figure 20. Global Bioactive Protein and Peptides Market: Cosmetic (2017-2022) & (KG)
Figure 21. Bioactive Protein and Peptides Consumed in Other
Figure 22. Global Bioactive Protein and Peptides Market: Other (2017-2022) & (KG)
Figure 23. Global Bioactive Protein and Peptides Sales Market Share by Application (2017-2022)
Figure 24. Global Bioactive Protein and Peptides Revenue Market Share by Application in 2021
Figure 25. Bioactive Protein and Peptides Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Bioactive Protein and Peptides Revenue Market Share by Company in 2021
Figure 27. Global Bioactive Protein and Peptides Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Bioactive Protein and Peptides Revenue Market Share by Geographic Region in 2021
Figure 29. Global Bioactive Protein and Peptides Sales Market Share by Region (2017-2022)
Figure 30. Global Bioactive Protein and Peptides Revenue Market Share by Country/Region in 2021
Figure 31. Americas Bioactive Protein and Peptides Sales 2017-2022 (KG)
Figure 32. Americas Bioactive Protein and Peptides Revenue 2017-2022 ($ Millions)
Figure 33. APAC Bioactive Protein and Peptides Sales 2017-2022 (KG)
Figure 34. APAC Bioactive Protein and Peptides Revenue 2017-2022 ($ Millions)
Figure 35. Europe Bioactive Protein and Peptides Sales 2017-2022 (KG)
Figure 36. Europe Bioactive Protein and Peptides Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Bioactive Protein and Peptides Sales 2017-2022 (KG)
Figure 38. Middle East & Africa Bioactive Protein and Peptides Revenue 2017-2022 ($ Millions)
Figure 39. Americas Bioactive Protein and Peptides Sales Market Share by Country in 2021
Figure 40. Americas Bioactive Protein and Peptides Revenue Market Share by Country in 2021
Figure 41. United States Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Bioactive Protein and Peptides Sales Market Share by Region in 2021
Figure 46. APAC Bioactive Protein and Peptides Revenue Market Share by Regions in 2021
Figure 47. China Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Bioactive Protein and Peptides Sales Market Share by Country in 2021
Figure 54. Europe Bioactive Protein and Peptides Revenue Market Share by Country in 2021
Figure 55. Germany Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Bioactive Protein and Peptides Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Bioactive Protein and Peptides Revenue Market Share by Country in 2021
Figure 62. Egypt Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Bioactive Protein and Peptides Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Bioactive Protein and Peptides in 2021
Figure 68. Manufacturing Process Analysis of Bioactive Protein and Peptides
Figure 69. Industry Chain Structure of Bioactive Protein and Peptides
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...